Jusqu'où faut-il baisser les taux de cholestérol en prévention primaire [How far the rates of cholesterol have to be lowered in primary prevention?]
| Data(s) |
2010
|
|---|---|
| Identificador |
http://serval.unil.ch/?id=serval:BIB_14961529F5F7 isbn:1660-9379[print], 1660-9379[linking] pmid:20373693 |
| Idioma(s) |
fr |
| Fonte |
Revue Médicale Suisse, vol. 6, no. 239, pp. 483-484 |
| Palavras-Chave | #Adult; Anticholesteremic Agents/economics; Anticholesteremic Agents/therapeutic use; Azetidines/economics; Azetidines/therapeutic use; Cardiovascular Diseases/epidemiology; Cardiovascular Diseases/prevention & control; Cholesterol/blood; Cholesterol, LDL/blood; Controlled Clinical Trials as Topic/economics; Cost-Benefit Analysis; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/economics; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Primary Prevention; Risk Factors; Simvastatin/economics; Simvastatin/therapeutic use |
| Tipo |
info:eu-repo/semantics/article article |
